$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh

$aawh Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000162828021011136 Filed on May 26, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$66.14M	$22.59M
YoY Change	192.75%
Cost Of Revenue	$36.47M	$15.10M
YoY Change	141.52%
Gross Profit	$29.67M	$7.492M
YoY Change	295.98%
Gross Profit Margin	44.86%	33.16%
Selling, General & Admin	$25.68M	$10.05M
YoY Change	155.52%
% of Gross Profit	86.56%	134.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.254M	$3.660M
YoY Change	70.87%
% of Gross Profit	21.08%	48.85%
Operating Expenses	$61.66M	$9.649M
YoY Change	539.0%
Operating Profit	-$31.99M	-$2.157M
YoY Change	1383.08%
Interest Expense	$7.337M	$2.530M
YoY Change	190.0%
% of Operating Profit
Other Income/Expense, Net	-$7.257M	-$2.524M
YoY Change	187.52%
Pretax Income	-$39.25M	-$4.681M
YoY Change	738.43%
Income Tax	$8.976M	$2.437M
% Of Pretax Income
Net Earnings	-$48.22M	-$7.478M
YoY Change	544.86%
Net Earnings / Revenue	-72.91%	-33.1%
Basic Earnings Per Share	-$0.45	-$0.08
Diluted Earnings Per Share	-$0.45	-$0.08
COMMON SHARES
Basic Shares Outstanding	106.4M shares	89.82M shares
Diluted Shares Outstanding	106.4M shares	89.82M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$62.63M
YoY Change
Cash & Equivalents	$62.63M	$12.71M
Short-Term Investments
Other Short-Term Assets	$23.19M
YoY Change
Inventory	$38.62M
Prepaid Expenses	$2.304M
Receivables	$7.115M
Other Receivables	$8.867M
Total Short-Term Assets	$141.1M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$150.1M
YoY Change
Goodwill	$24.30M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.65M
YoY Change
Total Long-Term Assets	$340.2M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$141.1M
Total Long-Term Assets	$340.2M
Total Assets	$481.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.34M
YoY Change
Accrued Expenses	$13.64M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$47.67M
YoY Change
Total Short-Term Liabilities	$126.1M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$201.6M
YoY Change
Other Long-Term Liabilities	$168.1M
YoY Change
Total Long-Term Liabilities	$201.6M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$126.1M
Total Long-Term Liabilities	$201.6M
Total Liabilities	$495.8M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$111.8M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.52M
YoY Change
Total Liabilities & Shareholders Equity	$481.3M
YoY Change

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$48.22M	-$7.478M
YoY Change	544.86%
Depreciation, Depletion And Amortization	$6.254M	$3.660M
YoY Change	70.87%
Cash From Operating Activities	-$7.829M	$3.861M
YoY Change	-302.77%
INVESTING ACTIVITIES
Capital Expenditures	$23.35M	$7.561M
YoY Change	208.83%
Acquisitions	$11.17M	$0.00
YoY Change
Other Investing Activities	-$11.85M
YoY Change
Cash From Investing Activities	-$35.20M	-$7.746M
YoY Change	354.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$1.286M	$0.00
YoY Change
Cash From Financing Activities	$48.21M	$3.793M
YoY Change	1171.13%
NET CHANGE
Cash From Operating Activities	-$7.829M	$3.861M
Cash From Investing Activities	-$35.20M	-$7.746M
Cash From Financing Activities	$48.21M	$3.793M
Net Change In Cash	$5.182M	-$92.00K
YoY Change	-5732.61%
FREE CASH FLOW
Cash From Operating Activities	-$7.829M	$3.861M
Capital Expenditures	$23.35M	$7.561M
Free Cash Flow	-$31.18M	-$3.700M
YoY Change	742.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001756390
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	333-254800
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	ASCEND WELLNESS HOLDINGS, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0602006
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1411 Broadway
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	16th Floor
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
CY2021Q1	dei	City Area Code CityAreaCode	781
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	703-7800
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62633000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56547000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	646000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1550000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7115000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6227000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	38620000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28997000	USD
CY2021Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	8867000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	8259000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	23188000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32598000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	141069000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	134178000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	150075000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120540000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95731000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84642000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47272000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	31224000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	50461000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	47669000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	24302000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	22798000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3191000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2395000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19648000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12734000	USD
CY2021Q1	us-gaap	Assets Assets	481288000	USD
CY2020Q4	us-gaap	Assets Assets	427748000	USD
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49816000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	59330000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2261000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2128000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	22500000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	18275000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3883000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4328000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	126129000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	115285000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	201556000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	152277000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	168122000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	156400000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	495807000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	423962000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Unit Issued CommonUnitIssued	107165000	shares
CY2021Q1	us-gaap	Common Unit Outstanding CommonUnitOutstanding	107165000	shares
CY2020Q4	us-gaap	Common Unit Issued CommonUnitIssued	106082000	shares
CY2021Q1	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	0	USD
CY2020Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	106082000	shares
CY2020Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	0	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97296000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	67378000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111815000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63592000	USD
CY2021Q1	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-14519000	USD
CY2020Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	3786000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	481288000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	427748000	USD
CY2021Q1	us-gaap	Revenues Revenues	66137000	USD
CY2020Q1	us-gaap	Revenues Revenues	22592000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	36470000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	15100000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	29667000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	7492000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25146000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9649000	USD
CY2021Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	36511000	USD
CY2020Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	61657000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	9649000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-31990000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2157000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	7337000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	2530000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	80000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7257000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2524000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39247000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4681000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8976000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2437000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-48223000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-7118000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	360000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-48223000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7478000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106443000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106443000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89821000	shares
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	94000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89821000	shares
CY2020Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	3786000	USD
CY2021Q1	us-gaap	Limited Liability Company Llc Members Equity Unit Based Compensation LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation	2487000	USD
CY2021Q1	aawh	Reserve For Equity Issued In Litigation Settlement ReserveForEquityIssuedInLitigationSettlement	27431000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-48223000	USD
CY2021Q1	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-14519000	USD
CY2019Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	34840000	USD
CY2020Q1	aawh	Adjustments To Members Equity Warrant Issued AdjustmentsToMembersEquityWarrantIssued	147000	USD
CY2020Q1	us-gaap	Limited Liability Company Llc Members Equity Unit Based Compensation LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation	185000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-7118000	USD
CY2020Q1	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	28054000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-48223000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-7118000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6254000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3660000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	352000	USD
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	3255000	USD
CY2020Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	814000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2487000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	185000	USD
CY2021Q1	aawh	Reserve Of Equity For Litigation Settlement Noncash ReserveOfEquityForLitigationSettlementNoncash	27431000	USD
CY2020Q1	aawh	Reserve Of Equity For Litigation Settlement Noncash ReserveOfEquityForLitigationSettlementNoncash	0	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-796000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-298000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	888000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1292000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11320000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	192000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	563000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-560000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6914000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	808000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16903000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2991000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-446000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2443000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	414000	USD
CY2020Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	84000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	4225000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2738000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7829000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3861000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23351000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7561000	USD
CY2021Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	760000	USD
CY2020Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	185000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	82000	USD
CY2020Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11174000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48214000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3793000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5182000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35203000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7746000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	49500000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	125000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1286000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2021Q1	aawh	Finance Lease Proceeds FinanceLeaseProceeds	0	USD
CY2020Q1	aawh	Finance Lease Proceeds FinanceLeaseProceeds	3750000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	82000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-92000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58097000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12805000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63279000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12713000	USD
CY2021Q1	us-gaap	Nature Of Operations NatureOfOperations	THE COMPANY AND NATURE OF OPERATIONS<div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ascend Wellness Holdings, Inc., which operates through its subsidiaries (collectively referred to as “Ascend Wellness,” “AWH,” “we,” “us,” “our,” or the “Company”), is a multi-state operator in the United States cannabis industry. AWH owns, manages, and operates cannabis cultivation facilities and dispensaries in several states across the United States, including Illinois, Massachusetts, Michigan, New Jersey, and Ohio. AWH is headquartered in New York, New York.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was originally formed on May 15, 2018 as Ascend Group Partners, LLC, and changed its name to “Ascend Wellness Holdings, LLC” on September 10, 2018. On April 22, 2021, Ascend Wellness Holdings, LLC converted into a Delaware corporation and changed its name to “Ascend Wellness Holdings, Inc.” and effected a 2-for-1 reverse stock split (the “Reverse Split”). We refer to this conversion throughout this filing as the “Conversion.” As a result of the Conversion, the members of Ascend Wellness Holdings, LLC became holders of shares of stock of Ascend Wellness Holdings, Inc. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the conversion, the Company has authorized 750,000 shares of Class A Common Shares with a par value of $0.001 per share, 100 shares of Class B common stock with a par value of $0.001 par value per share and 10,000 shares of preferred stock with a par value of $0.001 per share. The rights of the holders of Class A common stock and Class B common stock are identical, except for voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 1,000 votes per share and is convertible at any time into one share of Class A common stock at the option of the holder. See Note 12, “Members’ Equity,” for additional details.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and the financial information contained throughout this Form 10-Q are those of Ascend Wellness Holdings, LLC and its subsidiaries prior to the Conversion, but have been adjusted retrospectively for the Reverse Split for all periods presented. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2021, the Company completed an Initial Public Offering (“IPO”) of its Class A common stock, in which it issued and sold 10,000 shares of Class A common stock, excluding the underwriters’ over-allotment option, at a price of $8.00 per share with net proceeds of approximately $75,156 after deducting underwriting discounts and commissions, but excluding other direct offering expenses paid by us. On May 7, 2021, the underwriters exercised their over-allotment option in full and we received an additional $11,280, net of underwriting discounts of $720, for an additional 1,500 shares of Class A common stock. In connection with the IPO, the historical common units, Series Seed Preferred Units, Series Seed+ Preferred Units, and Real Estate Preferred Units automatically converted into a total of 110,521 shares of Class A common stock. Additionally, the Company’s convertible notes, plus accrued interest, converted into 37,388 shares of Class A Common Stock. See Note 12, “Members’ Equity,” for additional details.</span></div>The Company’s shares of Class A common stock are listed on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “AAWH.U.” We are an emerging growth company under federal securities laws and as such we are able to elect to follow scaled disclosure requirements for this filing.
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts. We base our estimates on historical experience, known or expected trends, independent valuations, and various other measurements that we believe to be reasonable under the circumstances. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with our current period presentation. These changes had no impact on our previously reported net loss.</span></div>
CY2020Q1	us-gaap	Revenues Revenues	22592000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62633000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56547000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	646000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1550000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63279000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58097000	USD
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	40966000	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13232000	shares
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q1	us-gaap	Revenues Revenues	66137000	USD
CY2020Q1	us-gaap	Revenues Revenues	22592000	USD
CY2020Q1	aawh	Business Acquisition Pro Forma Revenue Adjustments BusinessAcquisitionProFormaRevenueAdjustments	0	USD
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	29509000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-7118000	USD
CY2020Q1	aawh	Business Acquisition Pro Forma Net Income Loss Adjustments BusinessAcquisitionProFormaNetIncomeLossAdjustments	-3424000	USD
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8708000	USD
CY2020Q1	aawh	Business Acquisition Pro Forma Amortization Of Intangible Assets BusinessAcquisitionProFormaAmortizationOfIntangibleAssets	899000	USD
CY2020Q1	aawh	Business Acquisition Pro Forma Interest Expense Debt BusinessAcquisitionProFormaInterestExpenseDebt	2534000	USD
CY2020Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9000	USD
CY2021Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	11745000	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	7756000	USD
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16889000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13615000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9986000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7626000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	38620000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28997000	USD
CY2021Q1	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	6363000	USD
CY2020Q1	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	3398000	USD
CY2021Q1	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	6160000	USD
CY2020Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	5909000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6539000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	150075000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	159565000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	127079000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9490000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120540000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	2951000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	985000	USD
CY2021Q1	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	1956000	USD
CY2020Q1	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	896000	USD
CY2021Q1	aawh	Inventory Capitalized Depreciation InventoryCapitalizedDepreciation	1698000	USD
CY2020Q4	aawh	Inventory Capitalized Depreciation InventoryCapitalizedDepreciation	602000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58557000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	60061000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11285000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9600000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47272000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	50461000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1685000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1879000	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	22798000	USD
CY2021Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	1504000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	24302000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95731000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84642000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2261000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2128000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	168122000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	156400000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	170383000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	158528000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5774000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2060000	USD
CY2021Q1	aawh	Inventory Lease Costs Capitalized InventoryLeaseCostsCapitalized	4940000	USD
CY2020Q4	aawh	Inventory Lease Costs Capitalized InventoryLeaseCostsCapitalized	4913000	USD
CY2021Q1	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	652000	USD
CY2020Q1	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	606000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5069000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1998000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11442000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	425000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y9M18D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P17Y3M18D
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	16725000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.131
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.131
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22831000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23472000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24131000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	24820000	USD
CY2021Q1	aawh	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	335804000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	447783000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	277400000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	170383000	USD
CY2021Q1	aawh	Lessee Operating Lease Lease Not Yet Commenced Right Of Use Asset LesseeOperatingLeaseLeaseNotYetCommencedRightOfUseAsset	5000000	USD
CY2021Q1	aawh	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	5000000	USD
CY2021Q1	aawh	Financing Liability To Be Paid Remainder Of Fiscal Year FinancingLiabilityToBePaidRemainderOfFiscalYear	1522000	USD
CY2021Q1	aawh	Financing Liability To Be Paid Year One FinancingLiabilityToBePaidYearOne	2082000	USD
CY2021Q1	aawh	Financing Liability To Be Paid Year Two FinancingLiabilityToBePaidYearTwo	2143000	USD
CY2021Q1	aawh	Financing Liability To Be Paid Year Three FinancingLiabilityToBePaidYearThree	2206000	USD
CY2021Q1	aawh	Financing Liability To Be Paid Year Four FinancingLiabilityToBePaidYearFour	2271000	USD
CY2021Q1	aawh	Financing Liability To Be Paid After Year Four FinancingLiabilityToBePaidAfterYearFour	9149000	USD
CY2021Q1	aawh	Financing Liability FinancingLiability	19373000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	252385000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	215029000	USD
CY2021Q1	aawh	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	48687000	USD
CY2020Q4	aawh	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	60357000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1018000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	201556000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	152277000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1027000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	47669000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	59330000	USD
CY2021Q1	aawh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	203698000	USD
CY2020Q4	aawh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	154672000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2142000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2395000	USD
CY2021Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3426000	USD
CY2020Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1407000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3412000	USD
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	814000	USD
CY2021Q1	aawh	Interest On Financing Liability InterestOnFinancingLiability	499000	USD
CY2020Q1	aawh	Interest On Financing Liability InterestOnFinancingLiability	309000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7337000	USD
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2530000	USD
CY2021Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2021Q1	aawh	Restricted Stock No Par Value RestrictedStockNoParValue	0
CY2021Q1	us-gaap	Common Unit Outstanding CommonUnitOutstanding	107165000	shares
CY2020Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	106082000	shares
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y2M12D
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	10031000	shares
CY2021Q1	aawh	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Issued To Date ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssuedToDate	9944000	shares
CY2021Q1	aawh	Share Based Compensation Arrangement By Share Based Payment Award Restricted Award Exercise Period Following Ipo ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardExercisePeriodFollowingIPO	P6M
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
CY2021Q1	us-gaap	Gross Profit GrossProfit	29667000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	7492000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8976000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2437000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.303
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.325
CY2021Q1	aawh	Tenant Improvement Allowance Current TenantImprovementAllowanceCurrent	14292000	USD
CY2020Q4	aawh	Tenant Improvement Allowance Current TenantImprovementAllowanceCurrent	24349000	USD
CY2021Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4021000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4021000	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2304000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1205000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	23188000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32598000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2311000	USD
CY2021Q1	aawh	Construction Deposits Current ConstructionDepositsCurrent	1134000	USD
CY2020Q4	aawh	Construction Deposits Current ConstructionDepositsCurrent	712000	USD
CY2021Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1437000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	21339000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17763000	USD
CY2021Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	14480000	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	10556000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	7723000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	824000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2762000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2617000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2976000	USD
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49816000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	31224000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10052000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2465000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	5433000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	2768000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	3917000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	1457000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2419000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1951000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	534000	USD
CY2021Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	861000	USD
CY2020Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	210000	USD
CY2020Q1	us-gaap	Marketing Expense MarketingExpense	401000	USD
CY2021Q1	us-gaap	Other General Expense OtherGeneralExpense	1930000	USD
CY2020Q1	us-gaap	Other General Expense OtherGeneralExpense	397000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25146000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9649000	USD

Files In Submission

Name	View Source	Status
0001628280-21-011136-index-headers.html	Edgar Link	pending
0001628280-21-011136-index.html	Edgar Link	pending
0001628280-21-011136.txt	Edgar Link	pending
0001628280-21-011136-xbrl.zip	Edgar Link	pending
a03312021exhibit311.htm	Edgar Link	pending
a03312021exhibit312.htm	Edgar Link	pending
a03312021exhibit32.htm	Edgar Link	pending
aawh-20210331.htm	Edgar Link	pending
aawh-20210331.xsd	Edgar Link	pending
aawh-20210331_cal.xml	Edgar Link	unprocessable
aawh-20210331_def.xml	Edgar Link	unprocessable
aawh-20210331_g1.jpg	Edgar Link	pending
aawh-20210331_htm.xml	Edgar Link	completed
aawh-20210331_lab.xml	Edgar Link	unprocessable
aawh-20210331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh

2021 Q1 Form 10-Q Financial Statement

#000162828021011136 Filed on May 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAWH Ascend Wellness Holdings, Inc. Stock $aawh

2021 Q1 Form 10-Q Financial Statement

#000162828021011136 Filed on May 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh